Cargando…

Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial

BACKGROUND: To facilitate adherence to adaptive pain management behaviors after interdisciplinary multimodal pain treatment, we developed a mobile health app (AGRIPPA app) that contains two behavior regulation strategies. OBJECTIVE: The aims of this project are (1) to test the effectiveness of the A...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbers, Stefan, Pool, Jan, Wittink, Harriët, Köke, Albère, Scheffer, Else, Smeets, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463414/
https://www.ncbi.nlm.nih.gov/pubmed/32808931
http://dx.doi.org/10.2196/18632
_version_ 1783577126637666304
author Elbers, Stefan
Pool, Jan
Wittink, Harriët
Köke, Albère
Scheffer, Else
Smeets, Rob
author_facet Elbers, Stefan
Pool, Jan
Wittink, Harriët
Köke, Albère
Scheffer, Else
Smeets, Rob
author_sort Elbers, Stefan
collection PubMed
description BACKGROUND: To facilitate adherence to adaptive pain management behaviors after interdisciplinary multimodal pain treatment, we developed a mobile health app (AGRIPPA app) that contains two behavior regulation strategies. OBJECTIVE: The aims of this project are (1) to test the effectiveness of the AGRIPPA app on pain disability; (2) to determine the cost-effectiveness; and (3) to explore the levels of engagement and usability of app users. METHODS: We will perform a multicenter randomized controlled trial with two parallel groups. Within the 12-month inclusion period, we plan to recruit 158 adult patients with chronic pain during the initial stage of their interdisciplinary treatment program in one of the 6 participating centers. Participants will be randomly assigned to the standard treatment condition or to the enhanced treatment condition in which they will receive the AGRIPPA app. Patients will be monitored from the start of the treatment program until 12 months posttreatment. In our primary analysis, we will evaluate the difference over time of pain-related disability between the two conditions. Other outcome measures will include health-related quality of life, illness perceptions, pain self-efficacy, app system usage data, productivity loss, and health care expenses. RESULTS: The study was approved by the local Medical Research Ethics Committee in October 2019. As of March 20, 2020, we have recruited 88 patients. CONCLUSIONS: This study will be the first step in systematically evaluating the effectiveness and efficiency of the AGRIPPA app. After 3 years of development and feasibility testing, this formal evaluation will help determine to what extent the app will influence the maintenance of treatment gains over time. The outcomes of this trial will guide future decisions regarding uptake in clinical practice. TRIAL REGISTRATION: Netherlands Trial Register NL8076; https://www.trialregister.nl/trial/8076 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/18632
format Online
Article
Text
id pubmed-7463414
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-74634142020-09-17 Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial Elbers, Stefan Pool, Jan Wittink, Harriët Köke, Albère Scheffer, Else Smeets, Rob JMIR Res Protoc Protocol BACKGROUND: To facilitate adherence to adaptive pain management behaviors after interdisciplinary multimodal pain treatment, we developed a mobile health app (AGRIPPA app) that contains two behavior regulation strategies. OBJECTIVE: The aims of this project are (1) to test the effectiveness of the AGRIPPA app on pain disability; (2) to determine the cost-effectiveness; and (3) to explore the levels of engagement and usability of app users. METHODS: We will perform a multicenter randomized controlled trial with two parallel groups. Within the 12-month inclusion period, we plan to recruit 158 adult patients with chronic pain during the initial stage of their interdisciplinary treatment program in one of the 6 participating centers. Participants will be randomly assigned to the standard treatment condition or to the enhanced treatment condition in which they will receive the AGRIPPA app. Patients will be monitored from the start of the treatment program until 12 months posttreatment. In our primary analysis, we will evaluate the difference over time of pain-related disability between the two conditions. Other outcome measures will include health-related quality of life, illness perceptions, pain self-efficacy, app system usage data, productivity loss, and health care expenses. RESULTS: The study was approved by the local Medical Research Ethics Committee in October 2019. As of March 20, 2020, we have recruited 88 patients. CONCLUSIONS: This study will be the first step in systematically evaluating the effectiveness and efficiency of the AGRIPPA app. After 3 years of development and feasibility testing, this formal evaluation will help determine to what extent the app will influence the maintenance of treatment gains over time. The outcomes of this trial will guide future decisions regarding uptake in clinical practice. TRIAL REGISTRATION: Netherlands Trial Register NL8076; https://www.trialregister.nl/trial/8076 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/18632 JMIR Publications 2020-08-18 /pmc/articles/PMC7463414/ /pubmed/32808931 http://dx.doi.org/10.2196/18632 Text en ©Stefan Elbers, Jan Pool, Harriët Wittink, Albère Köke, Else Scheffer, Rob Smeets. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 18.08.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Elbers, Stefan
Pool, Jan
Wittink, Harriët
Köke, Albère
Scheffer, Else
Smeets, Rob
Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title_full Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title_fullStr Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title_full_unstemmed Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title_short Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial
title_sort mobile health app (agrippa) to prevent relapse after successful interdisciplinary treatment for patients with chronic pain: protocol for a randomized controlled trial
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463414/
https://www.ncbi.nlm.nih.gov/pubmed/32808931
http://dx.doi.org/10.2196/18632
work_keys_str_mv AT elbersstefan mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial
AT pooljan mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial
AT wittinkharriet mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial
AT kokealbere mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial
AT schefferelse mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial
AT smeetsrob mobilehealthappagrippatopreventrelapseaftersuccessfulinterdisciplinarytreatmentforpatientswithchronicpainprotocolforarandomizedcontrolledtrial